乌尔索西胆酸的不良反应:使用FAERS (2004-2023) 的现实世界药监测研究 (2004-2023)
Yahui Ni1, Xin Guan2, Xiaoxue Gao1
1Department of Gastroenterology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
这项研究分析了大规模的乌尔索西胆酸 (UDCA) 副作用数据,揭示了常见和意想不到的副作用. 这些发现旨在通过识别潜在风险来加强UDCA的安全临床应用.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 肝病学 肝病学是一种肝病学.
背景情况:
- Ursodeoxycholic 酸 (UDCA) 广泛用于肝胆道疾病.
- 目前,UDCA的大规模安全数据有限.
- 这项研究解决了全面UDCA安全评估的需要.
研究的目的:
- 使用现实世界的数据评估与UDCA相关的不良事件 (AE).
- 通过数据挖掘识别UDCA的潜在安全信号.
- 调查与UDCA相关的AE的性别特异性差异.
主要方法:
- 使用了FDA不良事件报告系统 (FAERS) 数据库.
- 提取了UDCA相关的AE报告,其中UDCA是主要的疑似药物.
- 应用了四种算法 (ROR,PRR,BCPNN,EBGM) 的不成比例分析.
主要成果:
- 确定了1651个与UDCA相关的AE.
- 已确认已知的副作用如腹和腹痛.
- 发现了意想不到的副作用,包括间歇性肺病和全细胞衰竭.
- 在27个器官系统类 (SOC) 中观察到UDCAAE,性别特异的信号差异.
结论:
- 在SOC和PT层面提供了UDCA相关AE的全面分析.
- 提供了优化UDCA临床使用和最大限度地减少副作用的见解.
- 促进UDCA在临床实践中的安全应用.
更多相关视频
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Affecting Factors
Drug Regulation
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drugs for Treatment of Ulcerative Colitis in IBD
